Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Continued as New Advances on Endocrine Metabolic and Immune Diseases

Personal Subscription
Volume: 2 Issue: 1, January

Current Approaches for the Treatment with Thyroid Hormone Analogs

Volume:2   Issue: 1
Pp: 1-8
Christian E. Wrede and Katharina Plikat
DOI: 10.2174/187221408783421282
Published on: 01 March, 2012

Aberrant Activation of Arachidonic Acid and Eicosanoid Pathways-Targets for Treating Prostate Cancer

Volume:2   Issue: 1
Pp: 9-15
Qihan Dong, Marzieh Niknami, Manish Patel and Paul Witting
DOI: 10.2174/187221408783421291
Published on: 01 March, 2012

Novel Plant Sterol and Stanol Derivatives with Beneficial Properties:Efficacy and Safety

Volume:2   Issue: 1
Pp: 16-23
Amalia E. Yanni
DOI: 10.2174/187221408783421309
Published on: 01 March, 2012

From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators

Volume:2   Issue: 1
Pp: 24-28
Selcuk Dagdelen
DOI: 10.2174/187221408783421273
Published on: 01 March, 2012

Anti-TSH Receptor Antibodies in the Congolese with Hyperthyroidism

Volume:2   Issue: 1
Pp: 29-34
Joseph B. Mabika, Symphorien D. Mpandamadi and Jena-Rene M. Kabangu
DOI: 10.2174/187221408783421246
Published on: 01 March, 2012

Periodontal Regenerative Materials and Their Applications: Goodness of Fit?

Volume:2   Issue: 1
Pp: 35-44
Mena Soory
DOI: 10.2174/187221408783421318
Published on: 01 March, 2012

Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders

Volume:2   Issue: 1
Pp: 57-61
Baris Akinci and Sena Yesil
DOI: 10.2174/187221408783421327
Published on: 01 March, 2012

Patent Selections

Volume:2   Issue: 1
Pp: 62-71
Bentham Science Publishers
DOI: 10.2174/187221408783421255
Published on: 01 March, 2012